Shusheng Li
- Infectious Diseases top 0.2%
- Neurology top 0.5%
- Molecular Biology
- Epidemiology top 5%
- Oncology top 5%
- Topics
- COVID-19 Clinical Research Studies (16 papers)Long-Term Effects of COVID-19 (10 papers)Sepsis Diagnosis and Treatment (9 papers)
- Journals
- Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Shusheng Li
73 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Infectious Diseases 3.0k
- Neurology 1.8k
- Molecular Biology 647
- Epidemiology 585
- Oncology 552
Countries citing papers authored by Shusheng Li
This map shows the geographic impact of Shusheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusheng Li more than expected).
Fields of papers citing papers by Shusheng Li
This network shows the impact of papers produced by Shusheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusheng Li. The network helps show where Shusheng Li may publish in the future.
Co-authorship network of co-authors of Shusheng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shusheng Li. A scholar is included among the top collaborators of Shusheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusheng Li. Shusheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 21 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 3 | |
| 7 | 16 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 9 | |
| 11 | 68 | |
| 12 | 3 | |
| 13 | 18 | |
| 14 | 38 | |
| 15 | 12 | |
| 16 | 9 | |
| 17 | 85 | |
| 18 | 0 | |
| 19 | 1 | |
| 20 | 53 |
About Shusheng Li
Shusheng Li is a scholar working on Critical Care and Intensive Care Medicine, Complementary and alternative medicine and Infectious Diseases, having authored 78 papers that have together received 4.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (10 papers) and Sepsis Diagnosis and Treatment (9 papers). The work is most often cited by research in Infectious Diseases (3.0k citations), Neurology (1.8k citations) and Critical Care and Intensive Care Medicine (215 citations). Shusheng Li has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Xiaoyun Zhang, Yong Cao, Qin Ning, Minxia Zhang, Wei Guo, Huilong Chen, Guang Chen, Xiaoping Luo, Xiaoping Zhang and Shiji Wu. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.